Tirzepatide
Price:55
Contact Info
- Add:湖南省長沙縣星沙街道開元東路95號華潤置地廣場二期16棟1317, Zip: 410100
- Contact: 劉澤斌
- Tel:19896262713
- Email:luis@hningredients.com
Other Products
Description
Additional Information
Product Description:
Novel dual GIP/GLP-1, Tirzepatide, Tirzepatide CAS No. 2023788-19-2
Tirzepatide is a once-weekly dual agonist of the glucose-dependent insulinotropic polypeptide (GIP, also known as gastric inhibitory polypeptide) receptor and the glucagon-like peptide-1 (GLP-1) receptor, developed by Eli Lilly.
Both GIP and GLP-1 are hormones secreted by the intestines that can stimulate insulin secretion. Tirzepatide integrates the actions of these two insulinotropic hormones into a single molecule, representing a new class of drugs for the treatment of type 2 diabetes.
| Industry Category | Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIs |
|---|---|
| Product Category | |
| Brand: | 湖南朗悅生物科技有限公司 |
| Spec: | 99% |
| Stock: | 9999 |
| Manufacturer: | |
| Origin: | China / Hunan / Changshashi |
